The Impact of Mutation on the Conformations and Recognition of Ubiquitin
突变对泛素构象和识别的影响
基本信息
- 批准号:8728042
- 负责人:
- 金额:$ 38.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-20 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAddressAffectBindingBiophysicsCatalysisCellsComplementCoupledCustomDataData CollectionDefectDiseaseEnzymesEukaryotaEvaluationFutureGeneticHereditary DiseaseIn VitroIndividualKnowledgeLibrariesLysineMapsMeasuresMediatingMethodsModelingMolecularMolecular ConformationMonitorMutateMutationPeptidylprolyl IsomerasePhenotypePolyubiquitinPopulationProtein ConformationProtein EngineeringProteinsRelative (related person)ResolutionRoentgen RaysRoleSaccharomyces cerevisiaeSamplingSideSiteSpecificitySpeedStructureSurfaceTemperatureTestingUbiquitinWorkX-Ray CrystallographyYeastsabstractingbasebiophysical modelcostdesigndisease-causing mutationdrug discoveryelectron densityengineering designgenome sequencingimprovedin vivointerestmolecular recognitionmutantprotein functionprotein protein interactionprotein structureresearch studyresponsesmall moleculetool
项目摘要
Project Summary/Abstract
Understanding how mutations affect protein structure significantly impacts drug discovery, protein engineering,
and the interpretation of individual genome sequences. However, the effects of many mutations, whether they
are beneficial or deleterious, cannot be understood from static protein structures alone. This problem is
especially significant for mutations that are located far away from active sites and interaction surfaces. If these
mutations do not have obvious large stability costs and are remote from functional sites, how can they
influence protein function? Rather than affecting the average structure defined by traditional X-ray
crystallography, this proposal determines how mutations may change the relative population of alternative
conformations. However, identifying alternative conformations and measuring their impact on protein function
represents an experimental challenge. To address these problems, this project builds on my methodological
advances to reveal alternative conformations by room temperature X-ray crystallography and electron density
sampling. I will study the protein-protein interactions of ubiquitin (Ub) in S. cerevisiae as a model to
understand how perturbing the relative populations of conformations impacts molecular recognition. Ub is an
ideal model to study the importance of alternative conformations because: previous studies have indicated that
diverse Ub conformations and poly-Ub linkages mediate distinct functional roles; its remarkable sequence and
functional conservation suggests that the populations of alternative conformations will be particularly
susceptible to mutation; and it is a small protein that can be comprehensively mutated. Moreover, I have
generated preliminary high-resolution room temperature X-ray data that complement previous NMR
experiments to define its accessible alternative conformations. Despite the central importance of different Ub
conformations for the cell, the general principles of how different Ub conformations are recognized and direct
the assembly of poly-Ub chains remain to be elucidated. To determine how mutations can affect the assembly
of specific poly-Ub chains, I will monitor how alternative side chain conformations of Ub participate in the
catalytic mechanism of the E2 Ubc1. To test how mutations afect Ub interactions in vivo, I will measure a
unique phenotypic profile for each Ub mutant. The central role of Ub in proteostasis and its sequence
conservation suggest that the principles I uncover will be widely applicable across all eukaryotes. By
measuring the impact of mutation on the conformational ensemble, this proposal addresses fundamental
biophysical models of interaction specificity, the organization of the Ub-interaction network, and the molecular
mechanisms of phenotypic change. Predictions of how mutation can change the relative populations of
conformations are especially important as increased sequencing efforts provide the genetic basis for rare
genetic diseases. This project will improve our knowledge and understanding of the relationship between
mutation, alternative conformations, and phenotype.
项目摘要/摘要
了解突变如何影响蛋白质结构会显着影响药物发现,蛋白质工程,
以及单个基因组序列的解释。但是,许多突变的影响,是否
是有益的或有害的,不能仅凭静态蛋白质结构来理解。这个问题是
对于远离活性位点和相互作用表面的突变特别重要。如果这些
突变没有明显的稳定成本明显,并且远离功能站点,它们如何才能
影响蛋白质功能?而不是影响传统X射线定义的平均结构
晶体学,该提案决定了突变如何改变替代的相对种群
构象。但是,确定替代构象并测量其对蛋白质功能的影响
代表一个实验挑战。为了解决这些问题,该项目建立在我的方法论基础上
通过室温X射线晶体学和电子密度揭示替代构象的进步
采样。我将研究酿酒酵母中泛素(UB)的蛋白质 - 蛋白质相互作用作为模型
了解构象相对群体的扰动如何影响分子识别。 ub是一个
研究替代构象重要性的理想模型,因为:以前的研究表明
不同的UB构象和多核链接介导了不同的功能角色;它的显着序列和
功能保护表明,替代构象的种群尤其是
容易受到突变;它是一种可以全面突变的小蛋白质。而且,我有
生成的初步高分辨率室温X射线数据,与先前的NMR相辅相成
定义其可访问的替代构象的实验。尽管不同的UB具有至关重要的重要性
细胞的构象,这是如何识别不同UB构象和直接的一般原理
多核链的组装仍有待阐明。确定突变如何影响组装
在特定的多核链中,我将监视UB的替代侧链构象如何参与
E2 UBC1的催化机制。为了测试突变如何与体内的UB相互作用相比,我将测量
每个UB突变体的独特表型曲线。 UB在蛋白抑制及其序列中的核心作用
保护表明,我发现的原则将在所有真核生物中广泛适用。经过
该提案衡量突变对构象合奏的影响,解决了基本
相互作用特异性的生物物理模型,UB互动网络的组织和分子
表型变化的机制。突变如何改变相对种群的预测
构象特别重要,因为增加的测序工作为罕见的遗传基础提供了
遗传疾病。该项目将提高我们对之间关系的知识和理解
突变,替代构象和表型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James Solomon Fraser其他文献
James Solomon Fraser的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James Solomon Fraser', 18)}}的其他基金
Discovering and Manipulating Macromolecular Conformational Ensembles
发现和操纵大分子构象整体
- 批准号:
10710024 - 财政年份:2022
- 资助金额:
$ 38.63万 - 项目类别:
Inhibiting Viral Macrodomains Using Structure-Based Design
使用基于结构的设计抑制病毒宏域
- 批准号:
10512631 - 财政年份:2022
- 资助金额:
$ 38.63万 - 项目类别:
Equipment for Discovering and Manipulating Macromolecular Conformational Ensembles
发现和操纵大分子构象整体的设备
- 批准号:
10797971 - 财政年份:2022
- 资助金额:
$ 38.63万 - 项目类别:
Discovering and Manipulating Macromolecular Conformational Ensembles
发现和操纵大分子构象整体
- 批准号:
10406110 - 财政年份:2022
- 资助金额:
$ 38.63万 - 项目类别:
The Impact of Mutation on the Conformations and Recognition of Ubiquitin
突变对泛素构象和识别的影响
- 批准号:
8538838 - 财政年份:2011
- 资助金额:
$ 38.63万 - 项目类别:
The Impact of Mutation on the Conformations and Recognition of Ubiquitin
突变对泛素构象和识别的影响
- 批准号:
8335438 - 财政年份:2011
- 资助金额:
$ 38.63万 - 项目类别:
The Impact of Mutation on the Conformations and Recognition of Ubiquitin
突变对泛素构象和识别的影响
- 批准号:
8213132 - 财政年份:2011
- 资助金额:
$ 38.63万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
宿主与 SARS-CoV-2 之间的战斗中病毒基因调控的新机制
- 批准号:
10725416 - 财政年份:2023
- 资助金额:
$ 38.63万 - 项目类别:
Molecular Mechanisms that Control mRNA Decapping in Biological Condensates
控制生物浓缩物中 mRNA 脱帽的分子机制
- 批准号:
10577994 - 财政年份:2023
- 资助金额:
$ 38.63万 - 项目类别:
Actions of spiropyrimidinetriones against bacterial type II topoisomerases
螺嘧啶三酮对细菌 II 型拓扑异构酶的作用
- 批准号:
10750473 - 财政年份:2023
- 资助金额:
$ 38.63万 - 项目类别:
Novel Therapeutics for Heart Failure: Modified, Water-Soluble Caveolin-1 Scaffolding Domain Peptides with Improved Characteristics for Drug Development
心力衰竭的新型疗法:修饰的水溶性 Caveolin-1 支架结构域肽,具有改进的药物开发特性
- 批准号:
10599654 - 财政年份:2023
- 资助金额:
$ 38.63万 - 项目类别:
Selective CYP26 inhibitors for the oral treatment of recalcitrant nodular acne.
用于口服治疗顽固性结节性痤疮的选择性 CYP26 抑制剂。
- 批准号:
10822482 - 财政年份:2023
- 资助金额:
$ 38.63万 - 项目类别: